Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Alexander

Showing results (1221-1230 of 1,241) with videos related to

Pageof 125
Sort By:
Journal of the American Chemical Society|June 25, 2024
Leptochelins A-C, Cytotoxic Metallophores Produced by Geographically Dispersed <i>Leptothoe</i> Strains of Marine CyanobacteriaNicole E Avalon, Mariana A Reis, Christopher C Thornburg, et al.
Genome Announcements|November 11, 2017
Genome Sequences of Subcluster K5 Mycobacteriophages AlleyCat, Edugator, and GuillsmingerRodney A King, Tina M Slowan-Pomeroy, Jodi E Thomas, et al.
Journal of Crohn'S & Colitis|November 9, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or TofacitinibZhigang Liu, James L Alexander, Kai Yee Eng, et al.
Nature Communications|March 17, 2022
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumabSimeng Lin, Nicholas A Kennedy, Aamir Saifuddin, et al.
The Lancet. Gastroenterology & Hepatology|September 11, 2022
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyJames L Alexander, Zhigang Liu, Diana Muñoz Sandoval, et al.
Eclinicalmedicine|October 16, 2023
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort studyZhigang Liu, James L Alexander, Kaixing Le, et al.
The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.
Epilepsia|January 24, 2026
Disparities across the pediatric epilepsy surgery journey: Referral, recommendation, and completion from a national consortiumMadison M Berl, Janelle Wagner, Avery Caraway, et al.
Journal of Cancer Research and Clinical Oncology|August 8, 2023
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinomaKevin C Flanagan, Jon Earls, Ian Schillebeeckx, et al.
Neuroimage|May 31, 2022
Insights from the IronTract challenge: Optimal methods for mapping brain pathways from multi-shell diffusion MRIChiara Maffei, Gabriel Girard, Kurt G Schilling, et al.
Pageof 125

Showing results (1221-1230 of 1,241) with videos related to

Sort By:
Pageof 125
Journal of the American Chemical Society|June 25, 2024
Leptochelins A-C, Cytotoxic Metallophores Produced by Geographically Dispersed <i>Leptothoe</i> Strains of Marine CyanobacteriaNicole E Avalon, Mariana A Reis, Christopher C Thornburg, et al.
Genome Announcements|November 11, 2017
Genome Sequences of Subcluster K5 Mycobacteriophages AlleyCat, Edugator, and GuillsmingerRodney A King, Tina M Slowan-Pomeroy, Jodi E Thomas, et al.
Journal of Crohn'S & Colitis|November 9, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or TofacitinibZhigang Liu, James L Alexander, Kai Yee Eng, et al.
Nature Communications|March 17, 2022
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumabSimeng Lin, Nicholas A Kennedy, Aamir Saifuddin, et al.
The Lancet. Gastroenterology & Hepatology|September 11, 2022
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyJames L Alexander, Zhigang Liu, Diana Muñoz Sandoval, et al.
Eclinicalmedicine|October 16, 2023
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort studyZhigang Liu, James L Alexander, Kaixing Le, et al.
The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.
Epilepsia|January 24, 2026
Disparities across the pediatric epilepsy surgery journey: Referral, recommendation, and completion from a national consortiumMadison M Berl, Janelle Wagner, Avery Caraway, et al.
Journal of Cancer Research and Clinical Oncology|August 8, 2023
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinomaKevin C Flanagan, Jon Earls, Ian Schillebeeckx, et al.
Neuroimage|May 31, 2022
Insights from the IronTract challenge: Optimal methods for mapping brain pathways from multi-shell diffusion MRIChiara Maffei, Gabriel Girard, Kurt G Schilling, et al.
Pageof 125